PEAK6 Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

PEAK6 Group’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-17,500	Closed	-$756K	–	5804
2015 Q3	$756K	Buy	17,500 +14,900	+573%	+$629K	﹤0.01%	2493
2015 Q2	$110K	Sell	2,600 -21,700	-89%	-$915K	﹤0.01%	4201
2015 Q1	$942K	Buy	24,300 +7,000	+40%	+$270K	0.01%	1936
2014 Q4	$582K	Buy	17,300 +15,800	+1,053%	+$558K	﹤0.01%	2446
2014 Q3	$53K	Sell	1,500 -21,800	-94%	-$747K	﹤0.01%	4119
2014 Q2	$766K	Buy	23,300 +21,800	+1,453%	+$746K	0.01%	1886
2014 Q1	$55K	Sell	1,500 -26,100	-95%	-$958K	﹤0.01%	4258
2013 Q4	$1.06M	Buy	+27,600	New	+$871K	0.01%	2020

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

PEAK6 Group's WX Position: Q4 2015 in Review

PEAK6 Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 95,900 shares — an estimated $4.14M sold.

PEAK6 Group first reported a position in WX in Q1 2014 and held it in 5 quarters. The position peaked at $4.14M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

PEAK6 Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
PEAK6 Group sold 95,900 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4.14M.
PEAK6 Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 5 quarters.
PEAK6 Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.14M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.